Physician profile
Bridget Geier
NPI 1073138731
$519.79
in general payments reported to CMS, 2019-2025
11 companies · $95.33 in 2025
The $95.33 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5.84 · 2022: $110 · 2023: $50.53 · 2024: $258 · 2025: $95.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $285.17 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $61.40 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $40.24 | 2024 | Vaxneuvance, Vaxelis, Gardasil |
| Lilly USA, LLC | $31.56 | 2024 | Mounjaro |
| Novartis Pharmaceuticals Corporation | $20.74 | 2023 | |
| Abbott Laboratories | $16.79 | 2025 | Freestyle Libre 3 |
| Abbvie INC. | $15.53 | 2023 | |
| Cranial Technologies, INC | $14.31 | 2025 | Doc Band |
| E.R. Squibb & Sons, L.L.C. | $14.20 | 2024 | Camzyos |
| Novo Nordisk INC | $14.01 | 2022 | |
| Genentech USA, INC. | $5.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Geier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.